Fabien Zoulim

Head, Viral Hepatitis Team at Centre Léon Bérard Lyon et Rhône-Alpes

Fabien Zoulim

Fabien Zoulim

Head, Viral Hepatitis Team at Centre Léon Bérard Lyon et Rhône-Alpes

Overview
RelSci Relationships

122

Number of Boards

4

Relationships
RelSci Relationships are individuals Fabien Zoulim likely has professional access to. A relationship does not necessarily indicate a personal connection.

General Director at Centre Léon Bérard Lyon et Rhône-Alpes

Relationship likelihood: Strong

Chief Executive Officer at Transgene SA

Relationship likelihood: Strong

Co-Founder at Novira Therapeutics, Inc.

Relationship likelihood: Strong

Vice President-Responsible Pharmacist, Quality & Deputy Chief Executive Officer, Member of the Management Committee at Transgene SA

Relationship likelihood: Strong

Deputy Chief Executive Officer, Director-Research & Development at Transgene SA

Relationship likelihood: Strong

President & Chief Executive Officer at ContraFect Corp.

Relationship likelihood: Strong

Scientific Advisor at NeuroVive Pharmaceutical AB

Relationship likelihood: Strong

Member, Scientific Advisory Board at Novira Therapeutics, Inc.

Relationship likelihood: Strong

Member, Scientific Advisory Board at Novira Therapeutics, Inc.

Relationship likelihood: Strong

Professional at McLaughlin-Rotman Centre for Global Health

Relationship likelihood: Strong

Paths to Fabien Zoulim
Potential Connections via
Relationship Science
You
Fabien Zoulim
Head, Viral Hepatitis Team at Centre Léon Bérard Lyon et Rhône-Alpes
Career History
Professor, Medicine
Current

The University of Lyon, located in Lyon and Saint-Étienne, France, is a center for higher education and research comprising 16 institutions of higher education. The three main universities in this center are: Claude Bernard University Lyon 1, which focuses upon health and science studies and has approximately 27,000 students; Lumière University Lyon 2, which focuses upon the social sciences and has about 30,000 students; Jean Moulin University Lyon 3, which focuses upon the law and humanities with about 20,000 students.[

Head, Hepatology Department
Current

Hospices Civils de Lyon is a company headquartered in Lyon, France and ultimately controlled by the Government of France, that provides health care services.

Head, Viral Hepatitis Team
Current
Boards & Committees
Member, Scientific Advisory Board
2016 - Current

Hepion Pharmaceuticals, Inc. engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.

Member, Scientific Advisory Board
Current

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.

Member, Scientific Advisory Board
Current

Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Fabien Zoulim. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Fabien Zoulim's profile does not indicate a business or promotional relationship of any kind between RelSci and Fabien Zoulim.